Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
Top Cited Papers
- 26 August 2011
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 378 (9792), 684-692
- https://doi.org/10.1016/s0140-6736(11)60784-8
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- C-reactive protein in the Heart Protection Study – Authors' replyThe Lancet, 2011
- Association Between Obesity, High-Sensitivity C-Reactive Protein ≥2 mg/L, and Subclinical AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection StudyThe Lancet, 2011
- Progression of Coronary Artery Calcium Predicts All-Cause MortalityJACC: Cardiovascular Imaging, 2010
- Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease PredictionJAMA, 2010
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- Clinical Implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. Population: Insights From the ARIC (Atherosclerosis Risk in Communities) StudyJournal of the American College of Cardiology, 2009
- Inflammation in Atherosclerosis From Pathophysiology to PracticeJournal of the American College of Cardiology, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008